The mechanism of increased renal susceptibility to toxic substances in the elderly

International Urology and Nephrology

Volumn 32, Issue 4, 2001, Pages 539-547

  Jerkić, Mirjana ^a   Vojvodić, Srećko ^a   López Novoa, JosÉMiguel ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Acute renal failure; Aging; Nephrotoxicity; Vasoconstrictors

Indexed keywords

ALLOPURINOL; AMINOGLYCOSIDE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPHYLLINE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANTIBIOTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CONTRAST MEDIUM; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); CYCLOSPORIN A; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; IMMUNOSUPPRESSIVE AGENT; LAXATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYTOIN; PHOSPHOLIPASE A2; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THROMBOCYTE ACTIVATING FACTOR; TOBRAMYCIN; TOXIC SUBSTANCE; UNINDEXED DRUG; VASOCONSTRICTOR AGENT;

ACUTE KIDNEY FAILURE; AGED; AGING; CELL PROLIFERATION; DEVELOPED COUNTRY; DISEASE SEVERITY; ELDERLY CARE; EXTRACELLULAR MATRIX; FIBROBLAST; GLOMERULUS FILTRATION RATE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERKALEMIA; HYPOKALEMIA; MESANGIUM CELL; NEPHROTOXICITY; POLYPHARMACY; POPULATION RISK; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TOXICITY TESTING; VASOCONSTRICTION; VASODILATATION;

AGED; AGING; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ENDOTHELINS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KIDNEY; KIDNEY FAILURE, ACUTE; PLATELET ACTIVATING FACTOR; REACTIVE OXYGEN SPECIES; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 0035727298     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014484101427     Document Type: Review

References (66)

1. Renal function in aging
2. The aging kidney: Insights from experimental studies
3. Aging and the kidney
4. Nephrologic complications of drug therapy in the elderly
5. Incidence and prognosis of acute renal failure in older patients
6. Age-related nephropathy in laboratory rats
7. The aging kidney
8. The aging kidney
9. Changes in renal function and morphology in aging laboratory animals
10. Acute renal failure in the aged
11. Diuretic use in the elderly: Potential for diuretic-induced hypokalemia
12. Pharmacokinetic and pharmacodynamic changes in the elderly: Clinical implications
13. Chronic salicylate intoxication. A common cause of morbidity in the elderly
14. Pharmacokinetics of salicylates in elderly
15. Decrease in kidney nitric oxide formation detected by electron paramagnetic resonance in acute renal failure due to contrast media
16. Acute renal failure in the elderly 1975-1990
17. Functional versus structural changes in the pathophysiology of acute ischemic renal failure in aging rats
18. Comparison of tobramycin nephrotoxicity in young adult and aged female rats
19. Cyclosporine A increases hypoxia and free radical production in rat kidneys: Prevention by dietary glycine
20. Potential interaction between prolonged cyclosporin administration and aging in the rat kidney
21. The effect of age and dosage route on experimental cyclosporine nephrotoxicity
22. Current concepts on the pathophysiology of acute renal failure
23. Renal renin and renin release in acute renal failure in the rat
24. Effect on aging on plasma renin and aldosterone in normal man
25. Renin gene expression in the aging kidney: Effect of sodium restriction
26. Renal and systemic adaptation to sodium restriction in aging rats
27. The effect of aging on the genetic expression of renin by mouse kidney
28. Down-regulation of the intrarenal renin-angiotensin system in the aging rat
29. Plasma renin activity decrease precedes spontaneous focal glomerular sclerosis in aging rats
30. Plasma renin activity and metabolic clearance rate of angiotensin II in the unstressed aging rat
31. Variation of intra-renal angiotensin II and angiotensin II receptors by acute renal ischemia in the aged rat
32. Effects of angiotensin-converting enzyme inhibition on mitochondrial number in the aging mouse
33. Effect of chronic ANG I-converting enzyme inhibition on aging processes. I. Kidney structure and function
34. Renin-angiotensin system, converting-enzyme inhibition, and kidney function in aging female rats
35. Renal responses to acute angiotensin II inhibition and administered angiotensin II in the aging, conscious, chronically catheterized rat
36. Altered renal vascular responses in aging rat kidney
37. Plasma endothelin levels in patients with acute renal failure
38. A role for endothelin in the maintenance of postischaemic renal failure in the rat
39. Role of nitric oxide in postischemic experimental acute renal failure
40. Sequential agonist activation and site-specific mediation of acute cyclosporine constriction in rat renal arterioles
41. Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity
42. Distribution of endothelin receptor subtypes in the rat kidney. Renal and haemodynamic effects of the mixed (A/B) endothelin receptor antagonist bosentan
43. Aging- and growth-dependent modulation of endothelin-1 gene expression in human vascular endothelial cells
44. The role of endothelin in the age dependent increase in renal vascular resistance in the rat kidney
45. Potential role of platelet activating factor in acute renal failure
46. Platelet activating factor antagonist protect against postischaemic acute renal failure in the rats
47. Action of cyclosporin A on cultured rat mesangial cells
48. Role of platelet activating factor in gentamicin and cisplatin nephrotoxicity
49. 2 in gentamicin-induced rat mesangial cell activation
50. Reactive oxygen species and platelet activating factor synthesis in age-related glomerulosclerosis
51. Age-related effects of platelet activating factor (PAF) in the isolated perfused rat heart
52. Pathogenesis of acute renal failure: New aspects
53. Effects of reactive oxygen species on cultured rat mesangial cells and isolated rat glomeruli
54. Effect of reactive oxygen species on endothelin-1 production by human mesangial cells
55. Oxygen free radicals in ischemic acute renal failure in the rat
56. Cyclosporine A nephrotoxicity: Role of thromboxane and reactive oxygen species
57. Reactive oxygen species mediate the effects of cyclosporine A on human cultured mesangial cells
58. Reactive oxygen species and biological aging: A mechanictic approach
59. -), superoxide dismutases, and related matters
60. Study of oxidative stress in the elderly
61. 1 in the rat kidney: Relationship to morphologic changes
62. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor
63. Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging
64. Advanced protein glycosylation in diabetes and aging
65. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine
66. Chronic aminoguanidine attenuates renal dysfunction and injury in aging rats